What Does the Democratic Sweep Mean for US Cannabis?
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
The Council of the European Union has adopted proposals that would see the whole hemp plant, including inflorescences and leaves, recognised as an ordinary agricultural product.
A Michigan cultivator is fighting to overturn a landmark court decision which has thrown the enforceability of cannabis industry contracts across the US into question.
Spain’s medical cannabis framework will finally start reaching patients over the coming days and weeks, marking a significant milestone in a four-year battle for access.
Frances’ incoming medical cannabis framework is expected to take the final step before it can be signed into law in the ‘coming weeks’.
Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be.
As the US cannabis industry eagerly awaits the judge’s final recommendation on whether to extend rescheduling, the next phase has already found itself caught in the weeds of bureaucracy.
The Global Cannabis Regulatory Summit (GCRS) has published a 100-page white paper that diagnoses a fragmented global regulatory landscape and sets out a working architecture to address it.
Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 baseline report, published in March 2024 (covering data collected in 2022).